167 related articles for article (PubMed ID: 36065695)
1. [Clinicopathological Features of Meningiomas in Tibet].
Luo HH; Huo Z; Wang Q; NIma Z; Duo B; Wei Q; DA Z; Wang H; Guo PP; Liao RQ; CIren Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):621-627. PubMed ID: 36065695
[TBL] [Abstract][Full Text] [Related]
2. [Expression of mucin-4 in meningiomas and its diagnostic significance].
Kong X; Tu YY; Zhong W; Wu HB
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):727-732. PubMed ID: 32610386
[No Abstract] [Full Text] [Related]
3. Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.
Hui M; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
J Postgrad Med; 2015; 61(1):32-5. PubMed ID: 25511215
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective Analysis of Pathological Diagnosis of Central Nervous System Diseases in Tibet].
Luo HH; Wang Q; Duo B; Huo Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):24-29. PubMed ID: 35300761
[TBL] [Abstract][Full Text] [Related]
5. MUC4 expression in meningiomas: under-recognized immunophenotype particularly in meningothelial and angiomatous subtypes.
Matsuyama A; Jotatsu M; Uchihashi K; Tsuda Y; Shiba E; Haratake J; Hisaoka M
Histopathology; 2019 Jan; 74(2):276-283. PubMed ID: 30112770
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel.
Agaimy A; Buslei R; Coras R; Rubin BP; Mentzel T
Histopathology; 2014 Jul; 65(1):60-70. PubMed ID: 24393170
[TBL] [Abstract][Full Text] [Related]
7. The correlation between phosphorylated Histone H3 (PHH3) and p-STAT3 in Meningiomas.
Ozek E; Akdag H; Tosuner Z; Abdallah A; Hatiboglu MA
Clin Neurol Neurosurg; 2019 Mar; 178():46-50. PubMed ID: 30710729
[TBL] [Abstract][Full Text] [Related]
8. A radiopathological classification of dural tail sign of meningiomas.
Qi ST; Liu Y; Pan J; Chotai S; Fang LX
J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
10. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
[TBL] [Abstract][Full Text] [Related]
11. H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
Behling F; Fodi C; Gepfner-Tuma I; Kaltenbach K; Renovanz M; Paulsen F; Skardelly M; Honegger J; Tatagiba M; ; Schittenhelm J; Tabatabai G
Neuro Oncol; 2021 Aug; 23(8):1273-1281. PubMed ID: 33367841
[TBL] [Abstract][Full Text] [Related]
12. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
[TBL] [Abstract][Full Text] [Related]
14. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparative immunohistochemical study.
Winek RR; Scheithauer BW; Wick MR
Am J Surg Pathol; 1989 Apr; 13(4):251-61. PubMed ID: 2648875
[TBL] [Abstract][Full Text] [Related]
15. Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature.
Elbabaa SK; Gokden M; Crawford JR; Kesari S; Saad AG
J Neurosurg Pediatr; 2012 Oct; 10(4):281-90. PubMed ID: 22900483
[TBL] [Abstract][Full Text] [Related]
16. Pathology of meningiomas.
Solomon DA; Pekmezci M
Handb Clin Neurol; 2020; 169():87-99. PubMed ID: 32553300
[TBL] [Abstract][Full Text] [Related]
17. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
18. WHO grade I meningioma subtypes: MRI features and pathological analysis.
Zhang T; Yu JM; Wang YQ; Yin DD; Fang LJ
Life Sci; 2018 Nov; 213():50-56. PubMed ID: 30153449
[TBL] [Abstract][Full Text] [Related]
19. Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature.
Thompson LD; Bouffard JP; Sandberg GD; Mena H
Mod Pathol; 2003 Mar; 16(3):236-45. PubMed ID: 12640104
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
